The proteasome as a potential target for chemotherapy of African trypanosomiasis

Drug Development Research

Volumn 68, Issue 5, 2007, Pages 205-212

  Steverding, Dietmar ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Anti trypanosomal drug development; Nagana disease; Proteasome; Sleeping sickness; Trypanosoma brucei

Indexed keywords

ANTITRYPANOSOMAL AGENT; CELL PROTEIN; DB 289; DIAMIDINE DERIVATIVE; DIMINAZENE ACETURATE; EFLORNITHINE; EPOXOMICIN; ETHIDIUM BROMIDE; ISOMETAMIDIUM CHLORIDE; LACTACYSTIN; MELARSOPROL; MG 262; N BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; NIFURTIMOX; PENTAMIDINE; PROTEASOME; PROTEASOME INHIBITOR; PROTEINASE; SURAMIN; TYROPEPTIN A; UNCLASSIFIED DRUG;

AFRICA; AFRICAN TRYPANOSOMIASIS; CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; DRUG TARGETING; ENZYME ACTIVITY; EUKARYOTIC CELL; HEALTH CARE POLICY; HUMAN; MAMMAL CELL; NONHUMAN; PROTEIN DEGRADATION; PROTOZOON; REVIEW; SENSITIVITY ANALYSIS; TRYPANOSOMA; TRYPANOSOMA BRUCEI;

EID: 36849004386     PISSN: 02724391     EISSN: 10982299     Source Type: Journal    
DOI: 10.1002/ddr.20188     Document Type: Review

References (43)

1. Adams J, Kauffman M. 2004. Development of the proteasome inhibitor VelcadeTM (Bortezomib). Cancer Invest 22:304-311.
2. Barrett MP, Burchmore RJ, Stich A, Lazzari JO, Frasch AC, Cazzulo JJ, Krishna S. 2003. The trypanosomiases. Lancet 362:1469-1480.
3. Bogyo M, McMaster JS, Gaczynska M, Tortorella D, Goldberg AL, Ploegh H. 1997. Covalent modification of the active threonine of proteasomal β subunits and the Escherichia coli homolog HsIV by a new class of inhibitors. Proc Natl Acad Sci USA 94:6629-6634.
4. Bogyo M, Shin S, McMaster JS, Ploegh HL. 1998. Substrate binding and sequence preference of the proteasome revealed by active-site-directed affinity probes. Chem Biol 5:307-320.
5. Claverol S, Burlet-Schiltz O, Girbal-Nenhauser E, Gairin JE, Monsarrat B. 2002. Mapping and structural dissection of human 20 S proteasome using proteomic approaches. Mol Cell Proteomics 1:567-578.
6. Coux O, Tanaka K, Goldberg AL. 1996. Structure and function of the 20S and 26S proteasomes. Annu Rev Biochem 65:801-847.
7. Cross GAM. 1990. Cellular and genetic aspects of antigenic variation in trypanosomes. Annu Rev Immunol 8:83-110.
8. Dick LR, Cruikshank AA, Grenier L, Melandri FD, Nunes SL, Stein RL. 1996. Mechanistic studies on the inactivation of the proteasome by lactacystin. A central role for clasto-lactacystin β-lactone. J Biol Chem 271:7273-7276.
9. Elofsson M, Splittgerber U, Myung J, Mohan R, Crews CM. 1999. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide α′,β′-epoxyketones. Chem Biol 6:811-822.
10. Fairlamb AH. 2003. Chemotherapy of human African trypanosomiasis: current and future prospects. Trends Parasitol 19:488-494.
11. Geerts S, Holmes PH, Diall O, Eisler MC. 2001. African bovine trypanosomiasis: the problem of drug resistance. Trends Parasitol 17:25-28.
12. Glenn RJ, Pemberton AJ, Royle HJ, Spackman RW, Smith E, Rivett AJ, Steverding D. 2004. Trypanocidal effect of α′,β′- epoxyketones indicates that trypanosomes are particularly sensitive to inhibitors of proteasome trypsin-like activity. Int J Antimicrob Agents 24:286-289.
13. Hua S-b, To W-Y, Nguyen TT, Wong M-L, Wang CC. 1996. Purification and characterization of proteasomes from Trypanosoma brucei. Mol Biochem Parasitol 78:33-46.
14. Huang L, Shen M, Chernushevich I, Burlingame AL, Wang CC, Robertson CD. 1999. Identification and isolation of three proteasome subunits and their encoding genes from Trypanosoma brucei. Mol Biochem Parasitol 102:211-223.
15. Huang L, Wang CC, Burlingame C. 2000. Investigation of intact subunit polypeptide composition of the 20S proteasome complex from rat liver using mass spectrometry. In: Burlingame AL, Carr SA, Baldwin MA, editors. Mass spectrometry in biology and medicine. Totowa, NJ: Humana Press. p 217-235.
16. Huang L, Jacob RJ, Pegg SC-H, Baldwin MA, Wang CC, Burlingame AL, Babbitt PC. 2001. Functional assignment of the 20S proteasome from Trypanosoma brucei using mass spectrometry and new bioinformatics approaches. J Biol Chem 276:28327-28339.
17. Kessler BM, Tortorella D, Altun M, Kisselev AF, Fiebiger E, Hekking BG, Ploegh HL, Overkleeft HS. 2001. Extended peptide-based inhibitors efficiently target the proteasome and revealed overlapping specificities of the catalytic β-subunits. Chem Biol 8:913-929.
18. Kinabo LD. 1993. Pharmacology of existing drugs for animal trypanosomiasis. Acta Trop 54:169-183.
19. Kisselev AF, Goldberg AL. 2001. Proteasome inhibitors: from research tools to drug candidates. Chem Biol 8:739-758.
20. Kopp F, Steiner R, Dahlmann B, Kuehn L, Reinauer H. 1986. Size and shape of the multicatalytic proteinase from rat skeletal muscle. Biochem Biophys Acta 872:253-260.
21. Kristjanson PM, Swallow BM, Rowlands GJ, Kruska RL, de Leeuw PN. 1999. Measuring the costs of African animal trypanosomosis, the potential benefits of control and returns to research. Agric Syst 59:79-98.
22. Kuzoe FAS. 1993. Current situation of African trypanosomiasis. Acta Trop 54:153-162.
23. Li Z, Zou C-B, Yao Y, Hoyt MA, McDonough S, Mackey ZB, Coffino P, Wang CC. 2002. An easily dissociated 26 S proteasome catalyzes an essential ubiquitin-mediated protein degradation pathway in Trypanosoma brucei. J Biol Chem 277:15486-15498.
24. Lomo PO, Coetzer THT, Lonsdale-Eccles JD. 1997. Characterization of a multicatalytic proteinase complex (20S proteasome) from Trypanosoma brucei brucei. Immunopharmacology 36:285-293.
25. Ma CP, Slaughter CA, DeMartino GN. 1992. Identification, purification, and characterization of a protein activator (PA28) of the 20 S proteasome (macropain). J Biol Chem 267:10515-10523.
26. Mathis AM, Holman JL, Sturk LM, Ismail MA, Boykin DW, Tidwell RR, Hall JE. 2006. Accumulation and intracellular distribution of antitrypanosomal diamidine compounds DB75 and DB820 in African trypanosomes. Antimicrob Agents Chemother 50:2185-2191.
27. Matovu E, Seebeck T, Enyaru JCK, Kaminsky R. 2001. Drug resistance in Trypanosoma brucei ssp., the causative agents of sleeping sickness in man and nagana in cattle. Microbes Infect 3:763-770.
28. Merschjohann K, Sporer F, Steverding D, Wink M. 2001. In vitro effect of alkaloids on bloodstream forms of Trypanosoma brucei and T. congolense. Planta Med 67:623-627.
29. Mutomba MC, To W-Y, Hyun WC, Wang CC. 1997. Inhibition of proteasome activity blocks cell cycle progression at specific phase boundaries in African trypanosomes. Mol Biochem Parasitol 90:491-504.
30. Nkemgu-Njinkeng J, Rosenkranz V, Wink M, Steverding D. 2002. Antitrypanosomal activities of proteasome inhibitors. Antimicrob Agents Chemother 46:2038-2040.
31. Omura S, Fujimoto T, Otoguro K, Matsuzaki K, Moriguchi R, Tanaka H, Sasaki Y. 1991. Lactacystin, a novel microbial metabolite, induces neuritogenesis of neuroblastoma cells. J Antibiot (Tokyo) 44:113-116.
32. Palmer JT, Rasnick D, Klaus JL, Brömme D. 1995. Vinyl sulfones as mechanism-based cysteine protease inhibitors. J Med Chem 38:3193-3196.
33. Pépin J, Milord F. 1994. The treatment of human African trypanosomiasis. Adv Parasitol 33:1-47.
34. Priotto G, Fogg C, Balasegaram M, Erphas O, Longa A, Checchi F, Ghabri S, Piola P. 2006. Three drug combinations for late-stage Trypanosoma brucei gambiense sleeping sickness: a randomized clinical trial in Uganda. PLoS Clin Trials 1:e39.
35. Steverding D, Spackman RW, Royle HJ, Glenn, RJ. 2005. Trypanocidal activities of trileucine methyl vinyl sulfone proteasome inhibitors. Parasitol Res 95:73-76.
36. Steverding D, Pemberton AJ, Royle H, Spackman RW, Rivett AJ. 2006. Evaluation of the anti-trypanosomal activity of tryropeptin A. Planta Med 72:761-763.
37. Tanaka K, Yoshimura T, Kumatori A, Ichihara A, Ikai A, Nishigai M, Kameyama K, Takagi T. 1988. Proteasomes (multi-protease complexes) as 20 S ring-shaped particles in a variety of eukaryotic cells. J Biol Chem 263:16209-16217.
38. To W-Y, Wang CC. 1997. Identification and characterization of an activated 20S proteasome in Trypanosoma brucei. FEBS Lett 404:253-262.
39. Turner CM. 1999. Antigenic variation in Trypanosoma brucei infections: an holistic view. J Cell Sci 112:3187-3192.
40. Wang CC, Bozdech Z, Liu C-I, Shipway A, Backes BJ, Harris JL, Bogyo M. 2003. Biochemical analysis of the 20 S proteasome of Trypanosoma brucei. J Biol Chem 278:15800-15808.
41. WHO. 2006. African trypanosomiasis (sleeping sickness). World Health Org Fact Sheet 259: http://www.who.int/mediacentre/factsheets/fs259/en/.
42. Wickware P. 2002. Resurrecting the resurrection drug. Nat Med 8:908-909.
43. Yao Y, Huang L, Krutchinsky A, Wong M-L, Standing KG, Burlingame AL, Wang CC. 1999. Structural and functional characterizations of the proteasome-activating protein PA26 from Trypanosoma brucei. J Biol Chem 274:33921-33930.